Search
Contineum Therapeutics Inc
CTNMAdd to Watchlist
15.100USD
-0.140-0.92%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
563.53MMarket Cap
LossP/E TTM
Contineum Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-2.17
0.84%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its current assets were 267.92M, with a year-on-year change of 29.81.
What are the total assets of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its total assets of Contineum Therapeutics Inc were 276.64M, with a year-on-year change of 29.97.
What are the total liabilities of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its total liabilities of Contineum Therapeutics Inc were 15.65M, with a year-on-year change of 5.90.
What is the total equity of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its total equity of Contineum Therapeutics Inc was 260.99M, with a year-on-year change of 31.77.
What is the net investment of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its net investment of Contineum Therapeutics Inc was -3.71M, with a year-on-year change of 94.68.
What is the net financing of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its net financing of Contineum Therapeutics Inc was 112.69M, with a year-on-year change of 3.38.
What is the Earnings Per Share (EPS) of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.17, with a year-on-year change of 0.84.
What is the Return on Equity (ROE) of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -26.13, with a year-on-year change of 59.77.
What is the Return on Assets (ROA) of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -24.51, with a year-on-year change of 0.48.
What is the operating profit of Contineum Therapeutics Inc?
According to Contineum Therapeutics Inc's FY2025 earnings report, its operating profit was -68.06M, with a year-on-year change of -33.73.